Logo image of NRDS

NERDWALLET INC-CL A (NRDS) Stock Fundamental Analysis

NASDAQ:NRDS - Nasdaq - US64082B1026 - Common Stock - Currency: USD

9.47  +0.29 (+3.16%)

After market: 9.47 0 (0%)

Fundamental Rating

6

NRDS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 53 industry peers in the Consumer Finance industry. NRDS has an excellent financial health rating, but there are some minor concerns on its profitability. NRDS is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NRDS was profitable.
NRDS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NRDS reported negative net income in multiple years.
NRDS had a positive operating cash flow in each of the past 5 years.
NRDS Yearly Net Income VS EBIT VS OCF VS FCFNRDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

With an excellent Return On Assets value of 6.21%, NRDS belongs to the best of the industry, outperforming 81.13% of the companies in the same industry.
NRDS has a Return On Equity (7.94%) which is comparable to the rest of the industry.
NRDS has a Return On Invested Capital (1.31%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 6.21%
ROE 7.94%
ROIC 1.31%
ROA(3y)0.58%
ROA(5y)-1.57%
ROE(3y)0.72%
ROE(5y)-2.17%
ROIC(3y)N/A
ROIC(5y)N/A
NRDS Yearly ROA, ROE, ROICNRDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 4.01%, NRDS is doing worse than 67.92% of the companies in the same industry.
NRDS's Profit Margin has declined in the last couple of years.
NRDS has a Operating Margin of 0.87%. This is in the lower half of the industry: NRDS underperforms 64.15% of its industry peers.
NRDS's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 90.82%, NRDS belongs to the best of the industry, outperforming 83.02% of the companies in the same industry.
In the last couple of years the Gross Margin of NRDS has remained more or less at the same level.
Industry RankSector Rank
OM 0.87%
PM (TTM) 4.01%
GM 90.82%
OM growth 3YN/A
OM growth 5Y-35.7%
PM growth 3YN/A
PM growth 5Y-16.05%
GM growth 3Y-0.63%
GM growth 5Y-0.47%
NRDS Yearly Profit, Operating, Gross MarginsNRDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. Health

2.1 Basic Checks

NRDS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
NRDS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, NRDS has more shares outstanding
The debt/assets ratio for NRDS is higher compared to a year ago.
NRDS Yearly Shares OutstandingNRDS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
NRDS Yearly Total Debt VS Total AssetsNRDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 5.45 indicates that NRDS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.45, NRDS belongs to the best of the industry, outperforming 96.23% of the companies in the same industry.
NRDS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.45
ROIC/WACC0.15
WACC8.93%
NRDS Yearly LT Debt VS Equity VS FCFNRDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

NRDS has a Current Ratio of 2.68. This indicates that NRDS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.68, NRDS is in the better half of the industry, outperforming 77.36% of the companies in the same industry.
A Quick Ratio of 2.68 indicates that NRDS has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.68, NRDS is doing good in the industry, outperforming 77.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 2.68
NRDS Yearly Current Assets VS Current LiabilitesNRDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 646.15% over the past year.
Measured over the past 5 years, NRDS shows a small growth in Earnings Per Share. The EPS has been growing by 0.81% on average per year.
Looking at the last year, NRDS shows a quite strong growth in Revenue. The Revenue has grown by 14.71% in the last year.
NRDS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.67% yearly.
EPS 1Y (TTM)646.15%
EPS 3YN/A
EPS 5Y0.81%
EPS Q2Q%191.67%
Revenue 1Y (TTM)14.71%
Revenue growth 3Y21.9%
Revenue growth 5Y24.67%
Sales Q2Q%24.1%

3.2 Future

Based on estimates for the next years, NRDS will show a very strong growth in Earnings Per Share. The EPS will grow by 22.05% on average per year.
Based on estimates for the next years, NRDS will show a small growth in Revenue. The Revenue will grow by 7.36% on average per year.
EPS Next Y-24.02%
EPS Next 2Y17.66%
EPS Next 3Y22.05%
EPS Next 5YN/A
Revenue Next Year18.35%
Revenue Next 2Y13.17%
Revenue Next 3Y10.16%
Revenue Next 5Y7.36%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NRDS Yearly Revenue VS EstimatesNRDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
NRDS Yearly EPS VS EstimatesNRDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.34, NRDS is valued correctly.
Based on the Price/Earnings ratio, NRDS is valued a bit more expensive than 60.38% of the companies in the same industry.
NRDS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.41.
Based on the Price/Forward Earnings ratio of 13.96, the valuation of NRDS can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NRDS is on the same level as its industry peers.
NRDS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 33.87.
Industry RankSector Rank
PE 13.34
Fwd PE 13.96
NRDS Price Earnings VS Forward Price EarningsNRDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NRDS indicates a somewhat cheap valuation: NRDS is cheaper than 71.70% of the companies listed in the same industry.
NRDS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 12.76
EV/EBITDA 10.66
NRDS Per share dataNRDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as NRDS's earnings are expected to grow with 22.05% in the coming years.
PEG (NY)N/A
PEG (5Y)16.39
EPS Next 2Y17.66%
EPS Next 3Y22.05%

0

5. Dividend

5.1 Amount

No dividends for NRDS!.
Industry RankSector Rank
Dividend Yield N/A

NERDWALLET INC-CL A

NASDAQ:NRDS (8/11/2025, 8:00:01 PM)

After market: 9.47 0 (0%)

9.47

+0.29 (+3.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners76.9%
Inst Owner Change0.24%
Ins Owners4.36%
Ins Owner Change1.18%
Market Cap705.61M
Analysts81.54
Price Target15.64 (65.15%)
Short Float %5.44%
Short Ratio5.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2308.4%
Min EPS beat(2)100%
Max EPS beat(2)4516.81%
EPS beat(4)3
Avg EPS beat(4)1165.02%
Min EPS beat(4)-125.51%
Max EPS beat(4)4516.81%
EPS beat(8)5
Avg EPS beat(8)542.18%
EPS beat(12)8
Avg EPS beat(12)383.83%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.35%
Min Revenue beat(2)6.9%
Max Revenue beat(2)7.8%
Revenue beat(4)3
Avg Revenue beat(4)5.91%
Min Revenue beat(4)-1.64%
Max Revenue beat(4)10.57%
Revenue beat(8)6
Avg Revenue beat(8)3.19%
Revenue beat(12)8
Avg Revenue beat(12)2.58%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)262.56%
EPS NY rev (1m)0%
EPS NY rev (3m)18.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 13.34
Fwd PE 13.96
P/S 0.96
P/FCF 12.76
P/OCF 9.31
P/B 1.9
P/tB 3.08
EV/EBITDA 10.66
EPS(TTM)0.71
EY7.5%
EPS(NY)0.68
Fwd EY7.16%
FCF(TTM)0.74
FCFY7.84%
OCF(TTM)1.02
OCFY10.74%
SpS9.86
BVpS4.99
TBVpS3.08
PEG (NY)N/A
PEG (5Y)16.39
Profitability
Industry RankSector Rank
ROA 6.21%
ROE 7.94%
ROCE 1.66%
ROIC 1.31%
ROICexc 1.73%
ROICexgc 3.37%
OM 0.87%
PM (TTM) 4.01%
GM 90.82%
FCFM 7.52%
ROA(3y)0.58%
ROA(5y)-1.57%
ROE(3y)0.72%
ROE(5y)-2.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-36.98%
ROICexc growth 3YN/A
ROICexc growth 5Y-44.38%
OM growth 3YN/A
OM growth 5Y-35.7%
PM growth 3YN/A
PM growth 5Y-16.05%
GM growth 3Y-0.63%
GM growth 5Y-0.47%
F-Score8
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 41.75%
Cap/Sales 2.79%
Interest Coverage 21.33
Cash Conversion 136.58%
Profit Quality 187.46%
Current Ratio 2.68
Quick Ratio 2.68
Altman-Z 5.45
F-Score8
WACC8.93%
ROIC/WACC0.15
Cap/Depr(3y)64.08%
Cap/Depr(5y)80.19%
Cap/Sales(3y)4.66%
Cap/Sales(5y)5.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)646.15%
EPS 3YN/A
EPS 5Y0.81%
EPS Q2Q%191.67%
EPS Next Y-24.02%
EPS Next 2Y17.66%
EPS Next 3Y22.05%
EPS Next 5YN/A
Revenue 1Y (TTM)14.71%
Revenue growth 3Y21.9%
Revenue growth 5Y24.67%
Sales Q2Q%24.1%
Revenue Next Year18.35%
Revenue Next 2Y13.17%
Revenue Next 3Y10.16%
Revenue Next 5Y7.36%
EBIT growth 1Y-32.63%
EBIT growth 3YN/A
EBIT growth 5Y-19.84%
EBIT Next Year3902.93%
EBIT Next 3Y280.47%
EBIT Next 5Y124.54%
FCF growth 1Y550.59%
FCF growth 3YN/A
FCF growth 5Y24.92%
OCF growth 1Y90.45%
OCF growth 3Y115.24%
OCF growth 5Y17.99%